.beta.-Galactosidase inhibitor GT-2558 and its derivatives

Drug – bio-affecting and body treating compositions – Fermentate of unknown chemical structure – Having a known elemental analysis

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424116, 435169, A61K 3500, C12P 106

Patent

active

044977972

ABSTRACT:
.beta.-Galactosidase inhibitors GT-2558, GT-2558-A, and GT-2558-B produced by a strain Streptomyces lydicus PA-5726, and their derivatives, acetyl-GT-2558-A and acetyl-GT-2558-B, useful as diagnostatic aid in .beta.-galactosidase deficiency, used in purification of enzymes, in research of new .beta.-galactosidase, in controlling sweetness of lactose-containing foods and in fermentation industry.

REFERENCES:
patent: 3978210 (1976-08-01), Mizuno et al.
patent: 3991183 (1976-11-01), Celmer et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

.beta.-Galactosidase inhibitor GT-2558 and its derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with .beta.-Galactosidase inhibitor GT-2558 and its derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .beta.-Galactosidase inhibitor GT-2558 and its derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2082449

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.